Leonid Timashev
Stock Analyst at RBC Capital
(4.92)
# 214
Out of 4,662 analysts
493
Total ratings
63.6%
Success rate
27.4%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology | Maintained: Buy | $5 | $3.01 | +66.11% | 18 | Aug 14, 2026 | |
| ADCT ADC Therapeutics | Maintained: Hold | $2 | $1.05 | +90.48% | 18 | Aug 14, 2026 | |
| CRMD CorMedix | Maintained: Buy | $14 | $8.14 | +71.99% | 17 | Aug 14, 2026 | |
| LEGN Legend Biotech | Rated: Buy | $59 → $58 | $20.27 | +186.14% | 46 | Aug 11, 2026 | |
| CATX Perspective Therapeutics | Maintained: Buy | $14 | $3.10 | +351.61% | 10 | Aug 10, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $258 → $273 | $245.85 | +11.04% | 14 | Aug 10, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $304 → $297 | $213.68 | +38.99% | 39 | Aug 10, 2026 | |
| BHVN Biohaven | Maintained: Buy | $22 → $23 | $14.85 | +54.88% | 31 | Aug 10, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $117 → $112 | $73.45 | +52.48% | 23 | Aug 7, 2026 | |
| EXEL Exelixis | Maintained: Hold | $46 | $50.61 | -9.11% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 | $126.33 | +54.36% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $6.67 | +109.90% | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 → $20 | $6.10 | +227.87% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $449 → $462 | $368.46 | +25.39% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $43.18 | +36.64% | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 → $79 | $74.71 | +5.74% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $20 | $22.99 | -13.01% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $451 → $450 | $356.01 | +26.40% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $182 → $203 | $202.00 | +0.50% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $21 | $13.29 | +58.01% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $50 | $26.67 | +87.48% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $36.68 | +30.86% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.39 | +38.99% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.98 | +25.63% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $49.45 | +13.25% | 22 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.8631 | +247.58% | 7 | May 14, 2026 |
Pyxis Oncology
Aug 14, 2026
Maintained: Buy
Price Target: $5
Current: $3.01
Upside: +66.11%
ADC Therapeutics
Aug 14, 2026
Maintained: Hold
Price Target: $2
Current: $1.05
Upside: +90.48%
CorMedix
Aug 14, 2026
Maintained: Buy
Price Target: $14
Current: $8.14
Upside: +71.99%
Legend Biotech
Aug 11, 2026
Rated: Buy
Price Target: $59 → $58
Current: $20.27
Upside: +186.14%
Perspective Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $14
Current: $3.10
Upside: +351.61%
Jazz Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $258 → $273
Current: $245.85
Upside: +11.04%
Axsome Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $304 → $297
Current: $213.68
Upside: +38.99%
Biohaven
Aug 10, 2026
Maintained: Buy
Price Target: $22 → $23
Current: $14.85
Upside: +54.88%
Cytokinetics
Aug 7, 2026
Maintained: Buy
Price Target: $117 → $112
Current: $73.45
Upside: +52.48%
Exelixis
Aug 6, 2026
Maintained: Hold
Price Target: $46
Current: $50.61
Upside: -9.11%
Aug 6, 2026
Maintained: Buy
Price Target: $195
Current: $126.33
Upside: +54.36%
Aug 6, 2026
Maintained: Buy
Price Target: $14
Current: $6.67
Upside: +109.90%
Aug 6, 2026
Rated: Buy
Price Target: $19 → $20
Current: $6.10
Upside: +227.87%
Aug 6, 2026
Rated: Buy
Price Target: $449 → $462
Current: $368.46
Upside: +25.39%
Aug 6, 2026
Maintained: Buy
Price Target: $59
Current: $43.18
Upside: +36.64%
Aug 6, 2026
Maintained: Buy
Price Target: $81 → $79
Current: $74.71
Upside: +5.74%
Aug 5, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $22.99
Upside: -13.01%
Aug 5, 2026
Rated: Buy
Price Target: $451 → $450
Current: $356.01
Upside: +26.40%
Aug 5, 2026
Maintained: Buy
Price Target: $182 → $203
Current: $202.00
Upside: +0.50%
Aug 5, 2026
Rated: Buy
Price Target: $22 → $21
Current: $13.29
Upside: +58.01%
Aug 5, 2026
Maintained: Buy
Price Target: $51 → $50
Current: $26.67
Upside: +87.48%
Aug 4, 2026
Maintained: Buy
Price Target: $48
Current: $36.68
Upside: +30.86%
Aug 3, 2026
Maintained: Buy
Price Target: $20
Current: $14.39
Upside: +38.99%
Jul 30, 2026
Maintained: Hold
Price Target: $5
Current: $3.98
Upside: +25.63%
Jul 28, 2026
Maintained: Buy
Price Target: $56
Current: $49.45
Upside: +13.25%
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.8631
Upside: +247.58%